OSUR OraSure Technologies, Inc.

NASDAQ
$3.59

OraSure Technologies, Inc. (OSUR) is expected to report earnings on February 8, 2027, after the market close. The consensus earnings estimate is a loss of $0.22 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +3.5% since its last earnings release on November 9, 2026.

OraSure Technologies Beat Consensus Estimates, Sees Revenue Below Estimates
Monday, November 9, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 8
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.22)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.53

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OraSure Technologies, Inc.

OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.